| The role of pro-inflammatory cytokines in neuroinflammation, neurogenesis and the neuroendocrine system in major depression YK Kim, KS Na, AM Myint, BE Leonard Progress in Neuro-Psychopharmacology and Biological Psychiatry 64, 277-284, 2016 | 620 | 2016 |
| Kynurenine pathway in major depression: evidence of impaired neuroprotection AM Myint, YK Kim, R Verkerk, S Scharpé, H Steinbusch, B Leonard Journal of affective disorders 98 (1-2), 143-151, 2007 | 611 | 2007 |
| The roles of BDNF in the pathophysiology of major depression and in antidepressant treatment BH Lee, YK Kim Psychiatry investigation 7 (4), 231, 2010 | 532 | 2010 |
| The role of pro-inflammatory cytokines in the neuroinflammation and neurogenesis of schizophrenia KS Na, HY Jung, YK Kim Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, 277-286, 2014 | 467 | 2014 |
| Cytokine–serotonin interaction through IDO: a neurodegeneration hypothesis of depression AM Myint, YK Kim Medical hypotheses 61 (5-6), 519-525, 2003 | 463 | 2003 |
| Cytokine imbalance in the pathophysiology of major depressive disorder YK Kim, KS Na, KH Shin, HY Jung, SH Choi, JB Kim Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (5), 1044-1053, 2007 | 457 | 2007 |
| Imbalance between pro-inflammatory and anti-inflammatory cytokines in bipolar disorder YK Kim, HG Jung, AM Myint, H Kim, SH Park Journal of affective disorders 104 (1-3), 91-95, 2007 | 452 | 2007 |
| Th1, Th2, and Th3 cytokine alterations in major depression AM Myint, BE Leonard, HWM Steinbusch, YK Kim Journal of affective disorders 88 (2), 167-173, 2005 | 416 | 2005 |
| Decreased plasma BDNF level in depressive patients BH Lee, H Kim, SH Park, YK Kim Journal of affective disorders 101 (1-3), 239-244, 2007 | 410 | 2007 |
| Low plasma BDNF is associated with suicidal behavior in major depression YK Kim, HP Lee, SD Won, EY Park, HY Lee, BH Lee, SW Lee, D Yoon, ... Progress in Neuro-Psychopharmacology and Biological Psychiatry 31 (1), 78-85, 2007 | 393 | 2007 |
| A double-blind trial of risperidone and haloperidol for the treatment of delirium CS Han, YK Kim Psychosomatics 45 (4), 297-301, 2004 | 384 | 2004 |
| Biological markers for anxiety disorders, OCD and PTSD: A consensus statement. Part II: Neurochemistry, neurophysiology and neurocognition B Bandelow, D Baldwin, M Abelli, B Bolea-Alamanac, M Bourin, ... The World Journal of Biological Psychiatry 18 (3), 162-214, 2017 | 362 | 2017 |
| Stress, the autonomic nervous system, and the immune-kynurenine pathway in the etiology of depression E Won, YK Kim Current neuropharmacology 14 (7), 665-673, 2016 | 331 | 2016 |
| Influence of the serotonin transporter promoter gene polymorphism on susceptibility to posttraumatic stress disorder HJ Lee, MS Lee, RH Kang, H Kim, SD Kim, BS Kee, YH Kim, YK Kim, ... Depression and anxiety 21 (3), 135-139, 2005 | 301 | 2005 |
| The plasma levels of interleukin-12 in schizophrenia, major depression, and bipolar mania: effects of psychotropic drugs YK Kim, IB Suh, H Kim, CS Han, CS Lim, SH Choi, J Licinio Molecular Psychiatry 7 (10), 1107-1114, 2002 | 291 | 2002 |
| Th1, Th2 and Th3 cytokine alteration in schizophrenia YK Kim, AM Myint, BH Lee, CS Han, HJ Lee, DJ Kim, BE Leonard Progress in Neuro-Psychopharmacology and Biological Psychiatry 28 (7), 1129-1134, 2004 | 266 | 2004 |
| The five-factor gambling motivation model HP Lee, PK Chae, HS Lee, YK Kim Psychiatry research 150 (1), 21-32, 2007 | 256 | 2007 |
| Network beyond IDO in psychiatric disorders: revisiting neurodegeneration hypothesis AM Myint, YK Kim Progress in Neuro-Psychopharmacology and Biological Psychiatry 48, 304-313, 2014 | 252 | 2014 |
| The role of CREB and BDNF in neurobiology and treatment of Alzheimer's disease M Amidfar, J de Oliveira, E Kucharska, J Budni, YK Kim Life sciences 257, 118020, 2020 | 244 | 2020 |
| The microbiota-gut-brain axis in neuropsychiatric disorders: pathophysiological mechanisms and novel treatments YK Kim, C Shin Current neuropharmacology 16 (5), 559-573, 2018 | 243 | 2018 |
